Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.

Doctor writing prescription | Image credit: 18percentgrey – stock.adobe.com

SGLT2i Prescriptions for Heart Failure Are Rising, but Vary Across US

By Hayden E. Klein

November 18th 2024

Of the 518 hospitals that had at least 10 eligible discharges, only 11 of them prescribed SGLT2 inhibitors to more than half of their patients.

AJMC Q&A with Dr Sanjula Jain | Background image credit: ipopba – stock.adobe.com

Rethinking Diabetes Care: Are New Therapies Adding Value or Cost?

By Hayden E. Klein

November 5th 2024

Sanjula Jain, PhD, chief research officer at Trilliant Health, discusses the rapid adoption of glucagon-like peptide 1 inhibitors for diabetes and preventive care for obesity and late-onset diabetes.

Doctor holding stethoscope to red heart | Image credit: lenets_tan – stock.adobe.com

How the Clinical Trial Gender Gap Affects Women’s Heart Care

By Hayden E. Klein

October 18th 2024

The history of women being left out of heart disease research has had significant consequences on heart health care today.

Population Health Strategies Are Vital for Tackling, Improving CKD Care

By Kyle Munz

October 18th 2024

Navdeep Tangri, MD, PhD, FRCP, University of Manitoba, speaks to the value of population health strategies in clinical approaches to care delivery for patients with chronic kidney disease (CKD).

<1 2 3

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions